U.S.-China trade booms as if virus, tariffs never happened #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/business/40003631

U.S.-China trade booms as if virus, tariffs never happened


China and the U.S. are shipping goods to each other at the briskest pace in years, making the worlds largest bilateral trade relationship look as if the protracted tariff war and pandemic never happened.

Eighteen months after the Trump administration signed the trade deal, the agreement has turned out to be a truce at best. The U.S. trade deficit hasn’t shrunk, most levies are still in place, and it hasn’t led to negotiations over other economic issues.

And yet, bilateral trade in goods is an area of stability in a relationship that has otherwise continued to deteriorate, with rising tension over Hong Kong, Taiwan, human rights, the origins of the Covid-19 pandemic, accusations of computer hacking and many other flashpoints.

Monthly two-way trade, which tumbled to $19 billion in February of last year amid shutdowns in Chinese factories, rebounded over the past year to new records, according to official Chinese data. And that boom looks set to continue, with China purchasing millions of tons of U.S. farm goods for this year and next and stuck-at-home U.S. consumers still shopping and importing in record amounts.

While the U.S. government’s numbers differ somewhat, the bustling trade has defied all expectations that the tariffs on hundreds of billions of dollars worth of merchandise would force a decoupling of supply chains. Instead, both sides have learned to live with the taxes, with Chinese firms buying more to fulfill the terms of the 2020 trade deal, and U.S. companies purchasing goods they can’t get elsewhere to meet elevated household demand fueled in part by trillions of dollars in government stimulus.

“We’ve seen the strong consumer demand that’s been occurring throughout the pandemic, and we’ve seen the import levels just go through the roof,” said Jonathan Gold, vice president of supply-chains and customs policy at the National Retail Federation, which represents vendors from mom-and-pop stores through the big-box chain behemoths. “That’s a strong sign that the economy continues to recover.”

ADVERTISEMENTx

Exports from South Korea and Taiwan to the U.S. have also risen over the same period, underscoring the strength of U.S. demand despite one of the worst outbreaks of Covid-19 of any nation.

Almost half of the $259 billion in cargo moving in and out of Los Angeles port — the U.S.’s biggest — involves China and Hong Kong. U.S. demand for goods continues unabated, with record inbound shipments to the port in May as companies start to restock ahead of the Christmas shopping season.

“All signs point to a robust second half of the year,” Los Angeles port Executive Director Gene Seroka said during a recent press briefing, noting that fall fashion, back-to-school, Halloween and holiday goods were already arriving on the docks.

With tariffs in place on more than $300 billion in imports from China, from footwear and clothing to electronics and bicycles and even pet food, many U.S. retailers are choosing to absorb the cost and squeezing their profit margins, the NRF’s Gold said. Some are passing these along to consumers.

Firms also are dealing with backlogs and bottlenecks at U.S. ports and increased shipping costs.

The number of container ships waiting to enter the twin ports of Los Angeles and Long Beach, California, increased to a 3 1/2-month high this week, while the spot shipping rate for a 40-foot container from Shanghai to Los Angeles is more than triple a year ago.

“Between the cost of the tariffs and the increased cost of transportation that we’re seeing, that’s having an impact on companies’ bottom line,” Gold said. “They’ve seen significant cost increases as a result of both the trade war and the transportation crisis we’re facing.”

The Biden administration hasn’t said whether it plans to continue with the deal and is reviewing U.S. policy toward China, but with U.S. Trade Representative Katherine Tai calling the trade relationship “unbalanced” and Treasury Secretary Janet Yellen saying the deal didn’t address the fundamental problems with China, the outlook is unfavorable.

On top of those tensions, China’s purchasing targets expire at the end of the year, and the nation is well behind where it promised it would be now. Those targets were initially seen as unrealistically high and problems like the Covid-19 pandemic or the grounding of the Boeing 737 Max jet put them even further out of reach.

Even if the deal is scrapped, the lesson from the past four or so years is that even if there is political will, it’s harder to stop or divert international trade than might have been thought.

With Beijing missing its purchase targets, China refraining from aircraft purchases and companies moving automotive production out of the U.S. to avoid getting hit with tariffs from the trade war, the agreement between the world’s two biggest economies is “pretty irrelevant at this stage,” said Chad Bown, a senior fellow at the Peterson Institute for International Economics, whose latest research has focused on the pact.

“China buys what China needs,” Bown said. “If it’s buying more of certain American products, it’s doing so probably out of its own interest.”

Published : July 23, 2021

By : Syndication Washington Post, Bloomberg · Eric Martin, James Mayger

Tech stocks lead S&P 500 gains; Treasurys climb #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/business/40003630

Tech stocks lead S&P 500 gains; Treasurys climb


Stocks approached their all-time highs, led by technology companies. Treasuries climbed, while the dollar barely moved.

The S&P 500 notched its biggest three-day advance since April, but gains paled in comparison to the previous two sessions. Giants Apple Inc., Microsoft Corp. and Amazon.com Inc. rallied, while firms closely tied to a broader reopening of businesses underperformed. Earlier Thursday, equities fell on news that multiple prominent websites were inaccessible to some users.

Rising earnings expectations have tempered worries over peaking growth and the spread of the delta coronavirus variant that roiled markets at the start of the week. Economic reports were mixed, showing sales of previously owned U.S. homes rose for the first time in five months, while jobless claims unexpectedly climbed.

“There’s going to be some choppiness in the market in the second half of the year, but we think it’s going to trend higher,” said Victoria Fernandez, chief market strategist at Crossmark Global Investments. “We have so much liquidity in the market right now, you have companies with a tremendous amount of cash on their balance sheets, you have rates at tremendous lows. There’s all these positive things that are happening that underlie the growth potential for the economy going forward.”

Among the corporate highlights, Union Pacific Corp., the largest publicly traded railroad, climbed as profit topped analysts’ projections. AT&T Inc. rose after beating Wall Street estimates amid surging subscriber growth. American Airlines Group Inc. and Southwest Airlines Co. slipped after cautious outlooks, while D.R. Horton Inc. sank on an unexpected plunge in new home orders.

As earnings continue to roll in, American stocks are regaining a leadership position in world markets. The ratio between the S&P 500 and an S&P Global gauge of shares listed outside the U.S. shows as much. After falling as much as 10.4% between September and February, the ratio rallied to a record on July 9 and again on Tuesday.

ADVERTISEMENTx

These are some of the main moves in markets:

Stocks

– The S&P 500 rose 0.2% as of 4 p.m. EDT

– The Nasdaq 100 rose 0.7%

– The Dow Jones industrial average was little changed

ADVERTISEMENT

– The MSCI World index rose 0.4%

– The Russell 2000 Index fell 1.5%

Currencies

– The Bloomberg Dollar Spot Index was little changed

– The euro fell 0.2% to $1.1770

ADVERTISEMENT

– The British pound rose 0.4% to $1.3767

– The Japanese yen rose 0.1% to 110.15 per dollar

Bonds

– The yield on 10-year Treasurys declined three basis points to 1.26%

– Germany’s 10-year yield declined three basis points to -0.43%

– Britain’s 10-year yield declined four basis points to 0.57%

Commodities

– West Texas Intermediate crude rose 2% to $71.69 a barrel

– Gold futures rose 0.2% to $1,811.50 an ounce

Published : July 23, 2021

By : Syndication Washington Post, Bloomberg · Rita Nazareth, Claire Ballentine

Company hit by massive ransomware attack obtains key to unlock customer files #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/business/40003629

Company hit by massive ransomware attack obtains key to unlock customer files


The company hit by a massive ransomware attack just before July Fourth weekend said it has obtained a computer key to unlock the files of hundreds of companies.

Company hit by massive ransomware attack obtains key to unlock customer files

Kaseya, an information technology company, said it got the universal decryptor key from a “trusted third party” and has validated that it works. Spokeswoman Dana Liedholm said Kaseya received the key Wednesday and has been working with customers to roll it out.

Liedholm declined to say whether Kaseya paid a ransom to obtain the key.

The hacking group behind the attack, called REvil, originally demanded $70 million to provide a universal decryptor key. But then the group disappeared online, leaving companies that may have wanted to pay a ransom high and dry.

Kaseya provides a software that allows companies to manage their computer systems, and it supplies that to managed service providers that in turn service tens of thousands of companies. The affected software spread to between 800 and 1,500 companies, Kaseya estimated. Those companies were then unable to access their files. Instead, they were prompted to pay a ransom to get a decryptor key that would return control to them. The ransom demands ranged from $45,000 for smaller companies up to $5 million for larger ones.

The attack hit a small town in Maryland, where staffers were unable to use their computers or send out utility bills, and a large grocery store chain in Sweden, which had to temporarily close its hundreds of locations.

ADVERTISEMENTx

The ransomware attack was the latest in a string of high-profile attacks stemming mainly from organized groups of hackers based in Eastern Europe. The frequency and severity of such attacks have increased in the past two years, especially as hackers band together to make the attacks more lucrative.

Hackers made their way into Kaseya’s software by discovering a vulnerability in the company’s software and using that to get into their system. But most ransomware attacks use relatively unsophisticated methods to break into computers, such as sending phishing emails that trick employees into opening an attachment or clicking on a link that downloads malicious software, which goes on to encrypt files and bar access to the whole network.

Some experts conservatively estimate that hackers received $412 million in ransom payments just last year.

A high-profile attack against Colonial Pipeline in May caused panicked fuel-buying and long lines at gas stations. Another attack, against meat supplier JBS, temporarily shut down meat plants across the United States. The company eventually paid hackers $11 million to restore its systems.

Published : July 23, 2021

By : The Washington Post · Rachel Lerman

An open letter from AstraZeneca #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/perspective/40003689

An open letter from AstraZeneca


An open letter to the people of Thailand

Dear friends in Thailand,

As AstraZeneca’s representative here, I see the challenges that all of us across the country face in the battle against COVID-19 and want to explain what we are doing to help.

The rising number of confirmed COVID-19 delta cases in Thailand concerns all of us at AstraZeneca. We are in constant contact with the Department for Disease Control on the virus’ evolving impact and on how we can help the national vaccination programme.

I want to assure you that for us, there is no higher priority than manufacturing vaccines that can protect you and your loved ones, as fast as possible.

We will leave no stone unturned.

Our vaccine is a ‘biologic’ product that starts with growing ‘living’ ingredients. Its manufacturing is complicated. The number of doses in each ‘harvested’ batch is never completely certain, especially in the early stages of a new supply chain. Even with that context, our projections show that in months with uninterrupted manufacturing we can supply five to six million doses in Thailand.

By the end of July, we will have delivered 11.3 million doses, as part of our overall commitment to deliver 61 million to Thailand. As of now, we have delivered nine million doses, with 2.3 million to be supplied to the Ministry of Public Health next week.

We are delivering in the fastest possible timeframe, however, given the gravity of the delta variant, we are leaving no stone unturned to accelerate supply further still. Together with our manufacturing partner, Siam Bioscience, we have initiated efforts to optimise the manufacturing process and we believe that in months with good ‘harvests’, we will be able to deliver more.

We are also scouring the 20+ supply chains in our worldwide manufacturing network to find additional vaccines for Southeast Asia, including Thailand. A global supply crunch for COVID-19 vaccines and shortages of the materials and components required to produce the vaccine, make it difficult to provide certainty today, but we are hopeful of importing additional doses in the months ahead.

An open letter from AstraZenecaAn open letter from AstraZeneca

COVID-19 is the biggest public health crisis of our generation. We at AstraZeneca see it as our duty to help, and thousands of our employees, and those of our partners, have devoted their lives this past year to do so. We do this at no profit during the pandemic because we believe that’s the right thing to do. The immediate needs of the pandemic are too large for us to take on alone, but we will not rest until you are vaccinated.

ADVERTISEMENTx

Our battle against COVID-19 is shared.

Since the start of the pandemic, you have shown the true heart and strength of Thailand. Polling suggests that over one third of the people in Thailand have donated money, food or supplies to support one another. We have witnessed remarkable solidarity within the community and across provincial borders. The battle against COVID-19 has been a marathon, but the one thing that will bring us closer to the finish line is running this race together, not just in Thailand but also internationally.

We in Thailand face an upsurge in cases today. Our brothers and sisters across ASEAN experience new lockdowns and rising fatalities also. New data from Canada shows that one dose of our vaccine is 87% effective against hospitalisation or death caused by the delta variant. The vaccines made in Thailand are of critical importance to our neighbours as much as they are to us here.

We share the same goal. To end the pandemic, we need to manage virus levels everywhere. As the virus ignores borders, the acceleration of COVID-19 in neighbouring countries is a threat to us in Thailand. This fight can only be won if we act together.

Yours sincerely,

James Teague

Managing Director, AstraZeneca Thailand

Published : July 24, 2021

By : THE NATION

Thai Central Chemical purchased alternative COVID-19 Vaccines “Sinopharm” from Chulabhorn Royal Academy for employees #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/business/40003613

Thai Central Chemical purchased alternative COVID-19 Vaccines “Sinopharm” from Chulabhorn Royal Academy for employees


Thai Central Chemical Public Company Limited purchased alternative COVID-19 Vaccines “Sinopharm” from Chulabhorn Royal Academy for employees in order to increase safety and build customer confidence in COVID-19 situation

Mr. Takahiro Yamashita – CEO & President (2nd Left), Mr. Munetake Kawakita (1st Right) and Mrs. Montha Kasadesinchai (2nd Right) – Executive Officer & Senior Vice President together with Ms. Atchara Siriwarasai (1st Left) – General Manager of Human Resource Division of Thai Central Chemical Public Company Limited (TCCC), the large producer and distributor of chemical fertilizer in Thailand under OX-Brand, purchased alternative COVID-19 Vaccines “Sinopharm” from Chulabhorn Royal Academy and encouraged employees to get vaccinated in order to build herd immunity, including build customer confidence in COVID-19 situation. TCCC places importance on employees with regard to takes into account the welfare and occupational safety which considered the valuable resources and key factors in the Company’s success.

Published : July 22, 2021

Thailand approves Roche/Regeneron’s “antibody cocktail” for COVID-19 patients #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/business/40003609

Thailand approves Roche/Regeneron’s “antibody cocktail” for COVID-19 patients


The antibody cocktail, which is a product jointly developed by Roche and Regeneron, is proven to be effective in treating patients aged 12 years and above, with mild to moderate COVID-19. The antibody cocktail can also be used to treat patients who are at high risk of severe or progressing to severe COVID-19, such as the elderlies and people with obesity or other chronic diseases.

the Food and Drug Administration (FDA) of Thailand announced the approval of the “antibody cocktail” for the treatment of COVID-19 patients, streamlining through an Emergency Use Authorization or EUA. Prior to this, the European Medicines Agency (EMA) has also announced their recommendation to treat COVID-19 patients using said antibody cocktail. Additionally, the United States Food and Drug Administration (USFDA) , India’s Central Drugs Standards Control Organisation (CDSCO) and many other countries have gradually approved the use of the antibody cocktail under Emergency Use Authorization (EUA).

Most recently, Japan became the first country in the world to grant a Special Approval Pathway (Marketing Authorisation) for the treatment of patients with mild to moderate COVID-19 with the antibody cocktail, based on the announcement from the Ministry of Health, Labour and Welfare (MHLW) under article 14-3 of the Pharmaceuticals and Medical Devices Act (PMDA).

The antibody cocktail, which is a product jointly developed by Roche and Regeneron, is proven to be effective in treating patients aged 12 years and above, with mild to moderate COVID-19. The antibody cocktail can also be used to treat patients who are at high risk of severe or progressing to severe COVID-19, such as the elderlies and people with obesity or other chronic diseases.

ADVERTISEMENTx

Sansanee Lerdlitruangsin, MD., Medical Director, Roche ThailandSansanee Lerdlitruangsin, MD., Medical Director, Roche Thailand

Sansanee Lerdlitruangsin, MD., Medical Director, Roche Thailand, stated “Based on a recent research on the efficacy of Roche’s antibody cocktail, results suggest that the product is able to reduce the viral load within the infected patient’s body. It can also reduce hospitalisation time by up to four days, as well as reduces the risk of progression to severe COVID-19, which leads hospitalisation or death by up to 70%. As for the question of whether or not the antibody cocktail has an ability to retain activity against emerging variants, such as Beta, Alpha, Gamma and Delta; despite in vitro studies from the National Institutes of Health (NIH) suggesting that the antibody cocktail is susceptible to SARS-CoV-2 variants, there are no in vivo efficacy as of now.”

Thailand approves Roche/Regeneron’s “antibody cocktail” for COVID-19 patientsThailand approves Roche/Regeneron’s “antibody cocktail” for COVID-19 patientsIn addition to being an innovative treatment that has been clinically proven to be effective, it can be said that the antibody cocktail is an important catalyst to help mitigate various impacts of this health crisis. This includes hospitalized patients, and patients waiting in line for hospital beds – who will be able to receive a timelier access to treatment due to faster hospital bed turnover rate. This in turn will help lessen caregivers’ anxiety, who are likely to grieve over the loss of their loved ones, help reduce the workload of medical professionals, and help medical centers sustain resource management, such as such as hospital beds, Personal Protective Equipment (PPE), and ventilators.

Mr. Farid Bidgoli, General Manager, Roche Thailand, Myanmar, Cambodia and Laos stated, Mr. Farid Bidgoli, General Manager, Roche Thailand, Myanmar, Cambodia and Laos stated,Mr. Farid Bidgoli, General Manager, Roche Thailand, Myanmar, Cambodia and Laos stated, “Amidst the current pandemic that is increasing in severity, Roche Thailand is committed to leveraging our expertise and excellence in science to drive medical advancements and collaborate with various organisations to support medical professionals in fighting this deadly disease. I want to extend my deepest gratitude towards all stakeholders involved in caring for the health of the population and recognising the necessity of allowing access to effective medicines which significantly reduce the length of hospitalization and relieve anxiety from the risk of progressing to severe COVID-19 or death. I truly believe that timely access to diagnostic solutions and treatment innovations will be a key helping hand for Thailand to tackle with and put an end to this devastating pandemic once and for all.”

About the antibody cocktail

• The antibody cocktail is a combination of two Monoclonal antibodies, namely antibodies produced by the VelocImmune® mice which have been genetically-modified to have a human immune system, and antibodies identified from humans who have recovered from COVID-19.

• The antibody cocktail exhibits neutralisation activity and binds to the spike protein receptor of SARS-CoV-2, leading to inhibition of infection of host cells.

• According to in-vitro studies, the antibody cocktail shows susceptibility toSAR-CoV2 variants.

Thailand approves Roche/Regeneron’s “antibody cocktail” for COVID-19 patientsThailand approves Roche/Regeneron’s “antibody cocktail” for COVID-19 patients

Roche’s COVID-19 Responses

As a leading healthcare company, Roche is doing all it can to support countries in minimising the impact of COVID-19. Roche has developed a growing number of diagnostic solutions which help detect and diagnose the infection in patients, as well as providing digital support to healthcare systems, and Roche continues to identify, develop and support potential therapies which can play a role in treating the disease.

Roche understands the impact of COVID-19 goes beyond those who contract it, which is why the company is working with healthcare providers, laboratories, authorities and organisations to help make sure that patients continue to receive the tests, treatment and care they need during these challenging times. The pandemic gave Roche an important lesson of partnering with private and public sectors to make healthcare stronger and more sustainable in the future.

As for the third wave, Roche continues to leverage its strengths and expertise to fight the disease and alleviate the severity of the pandemic.

o Strengths in diagnostics: SARS-CoV-2 Rapid Antigen Test (nasopharyngeal) for hospital settings, and Rapid Antigen Test (nasal) for home use.

o Strengths in pharmaceuticals: Rheumatoid arthritis drug recommended by the World Health Organization for treating hospitalised patients with severe or critical COVID-19, and the new antibody cocktail.

“Roche also has another innovative drug used for rheumatoid arthritis, in which on July 6, 2021, the World Health Organization (WHO) has issued new treatment guidelines for the clinical management of COVID-19, by recommending the use of said rheumatoid arthritis drug to treat patients with moderate to severe pneumonia associated with COVID-19. This rheumatoid arthritis drug has been widely used across hospitals worldwide during the pandemic, and found that patients have shown positive responsiveness to the drug,” Sansanee Lerdlitruangsin added.

Published : July 22, 2021

SCB wins 3 Asian Leadership Awards 2021 for best COVID-19 risk management #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/business/40003603

SCB wins 3 Asian Leadership Awards 2021 for best COVID-19 risk management


Siam Commercial Bank (SCB) was recently the recipient of three Asian Leadership Awards 2021 for operational risk management amid the COVID-19 pandemic, reflecting its proactive corporate role in handling the crisis and its workforce solutions to leverage its digital technology capabilities toward a future organization.

SCB Senior Executive Vice President and Chief Risk Officer Anucha Laokwansatit recently reiterated that SCB has never stopped to follow its resilient and effective business continuity plan to maintain productivity and deliver convenient experience and services to customers amid the challenging COVID-19 pandemic. Risk management measures in place include a work from home policy, strict safety measures, branch openings as necessary, preventive and risk mitigating measures for branch staff, and more. SCB was among the first companies in Thailand to immediately announce a work from home policy early in the COVID-19 outbreak, so as to maintain social distancing and help reduce the spread of the disease. At the same time, SCB increased the capacity of its IT infrastructure to support digital banking transactions and boosted call center staff numbers to support customers in need.

ADVERTISEMENTx

SCB wins 3 Asian Leadership Awards 2021 for best COVID-19 risk managementSCB wins 3 Asian Leadership Awards 2021 for best COVID-19 risk management

Thanks to the Bank’s proactive risk management during the COVID-19 pandemic over the past year, SCB received overwhelming votes and won three on-line Asian Leadership Awards 2021 on July 15, 2021. The Best COVID-19 Solution for Workforce Management, the Best COVID-19 Remote Monitoring Solution, and the Most Innovative Solution for COVID-19 awards reflect SCB’s outstanding corporate management during the COVID-19 crisis, enabling operations following the Bank’s highly resilient and effective business continuity plan.

The Asian Leadership Awards is an annual event revealing the best potential and leadership among companies in Asia. Leading companies winning awards at the event have passed economic challenges amid the COVID-19 crisis with strong determination to make a change and foster corporate sustainability.

SCB wins 3 Asian Leadership Awards 2021 for best COVID-19 risk managementSCB wins 3 Asian Leadership Awards 2021 for best COVID-19 risk management

“SCB executives have noticed significant impacts from the COVID-19 outbreak since early 2020. Since then, almost 80% of SCB staff have adapted to working from anywhere for over 16 months. This measure is to protect our most valuable resource, our staff, from COVID-19. And as a result of our IT infrastructure revamp and digital transformation, the capacity of our digital platforms such as the SCB Easy App has increased to offer more convenient and effective online services and a better customer experience amid higher demand during the pandemic.” Anucha said.

SCB wins 3 Asian Leadership Awards 2021 for best COVID-19 risk managementSCB wins 3 Asian Leadership Awards 2021 for best COVID-19 risk management

In terms of staff well-being and productivity, SCB has provided an SCB Telecare program offering telemedicine services, a staff loan program, MS Teams for online working and communication with co-workers to maintain productivity, reduced the risk of COVID-19 exposure, kept staff up-to-date with important news and information, increased safety measures for front-line staff who meet customers face-to-face, and ensured rigorous branch equipment maintenance and surface disinfection in compliance with safety measures of the Ministry of Public Health.

SCB risk management also follows the Bank of Thailand’s guidelines on helping all customer segments affected by the pandemic with supportive measures for post-pandemic economic recovery.

Published : July 22, 2021

THAI Announces Flight Adjustment #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/business/40003601

THAI Announces Flight Adjustment


The guideline instructed airline operators to cease all domestic operations to and from the maximum and strictly controlled provinces (dark red zone) which will take effect from 21 July 2021 until further notice.

The Civil Aviation Authority of Thailand (CAAT) recently issued a public announcement related to guidelines for airline operators on domestic flight operations as the COVID-19 situation has worsened. The guideline instructed airline operators to cease all domestic operations to and from the maximum and strictly controlled provinces (dark red zone) which will take effect from 21 July 2021 until further notice. In response to this guideline, Mr. Nond Kalinta, Chief Commercial Officer, Thai Airways International Public Company Limited (THAI) said THAI has adjusted two of its flight operations between Phuket and European destinations to provide more conveniences to passengers of the Phuket Sandbox programme with the following details:

• TG922 routing Bangkok – Frankfurt will be adjusted as:

Bangkok – Phuket – Frankfurt on every Thursday starting 29 July 2021

departing from Bangkok at 19:55 hours and arriving in Phuket at 21:25 hours and

departing from Phuket at 22:40 hours and arriving in Frankfurt at 06:00 hours (local time) the following day.

• TG916 routing Bangkok – London will be adjusted as:

Bangkok – Phuket – London on every Friday starting 30 July 2021

departing from Bangkok at 21:10 hours and arriving in Phuket at 22:40 hours and

departing from Phuket at 23:55 hours and arriving in London at 07:15 hours (local time) the following day.

THAI will be pleased to accommodate customers holding THAI tickets from Phuket to Paris, Zurich or Copenhagen who wish to travel on the adjusted flights to change their tickets free of charge. For more information on the flight schedule or reservation, please visit our website: thaiairways.com, THAI Sales Office or call THAI Contact Center at Tel: (662) 356-1111 (during 08:00 – 17:00 hours).

Published : July 22, 2021

SET rises 0.74% despite pressure from Covid, fund outflows #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/business/40003620

SET rises 0.74% despite pressure from Covid, fund outflows


The Stock Exchange of Thailand (SET) Index closed at 1,552.36 on Thursday, up 11.48 points or 0.74 per cent. Transactions totalled THB69.68 billion with an index high of 1,554.65 and a low of 1,546.26.

In the morning session, Krungsri Securities predicted the day’s index would fluctuate between 1,530 and 1,550 points despite a rise in the oil price after US oil storage slid to its lowest level in 18 months.

“The SET Index is being pressured by concern that Covid-19 Delta outbreaks here and overseas will hit global economic recovery, as well as the outflow of foreign funds,” Krungsri Securities said.

ADVERTISEMENTx

The 10 stocks with the highest trade value today were SCB, KBANK, KCE, HANA, GPSC, BBL, GUNKUL, CPF, PTTGC and ADVANC.

Other Asian indices were up:

China’s Shanghai SE Composite Index closed at 3,574.73, up 12.07 points or 0.34 per cent, while the Shenzhen SE Component Index closed at 15,262.19, up 49.59 points or 0.33 per cent.

Hong Kong’s Hang Seng Index closed at 27,723.84, up 499.26 points or 1.83 per cent.

South Korea’s KOSPI closed at 3,250.21, up 34.30 points or 1.07 per cent.

Taiwan’s TAIEX closed at 17,572.33, up 113.54 points or 0.65 per cent.

Japan’s Nikkei Index was closed for Marine Day.

Published : July 22, 2021

By : The Nation

SET Index likely to fluctuate today as Delta variant, foreign fund outflows fuel concern #SootinClaimon.Com

#SootinClaimon.Com : ขอบคุณแหล่งข้อมูล : หนังสือพิมพ์ The Nation.

https://www.nationthailand.com/business/40003599

SET Index likely to fluctuate today as Delta variant, foreign fund outflows fuel concern


The Stock Exchange of Thailand (SET) Index rose by 8.25 points or 0.54 per cent to 1,549.13 on Thursday morning.

Krungsri Securities predicted the day’s index would fluctuate between 1,530 and 1,550 points despite a rise in the oil price after US oil storage slid to its lowest level in 18 months.

“The worry that outbreaks of the Covid-19 Delta variant both domestic and overseas will hit global economic recovery plus the outflow of foreign funds would pressure the SET Index,” Krungsri Securities said.

ADVERTISEMENTx

It recommended investors buy:

▪︎ Hana, KCE, TU, CPF, Asian and EPG, which benefit from a weakening baht.

▪︎ BCH, CHG, BDMS, HMPro, Global, DoHome, BEM, CKP, CBG, OSP, Ichi, GPSC, BEC, Gunkul, JWD, Wice, Sonic and NER, whose second-quarter business turnover is expected to improve.

The SET Index closed at 1,540.88 on Wednesday, up 2.02 points or 0.13 per cent. Transactions totalled THB73.68 billion with an index high of 1,545.39 and a low of 1,532.34.

Published : July 22, 2021

By : The Nation